Recently over December 10-12, 2015, I attended the World Stem Cell Summit in Atlanta, GA, where 1,200 attendees from more than 40 different countries were present. It was an incredible opportunity for relationship building and networking across the stem cell community.
Across the dozens of one-on-one exchanges that I had over the three day conference, I universally received positive feedback for the amount of high-quality, free information that BioInformant shares about the stem cell and cord blood industry. We distribute this information through our blog (which you are reading) and across our social media channels. There is a reason that we are a Top Influencer for stem cells on LinkedIn and the fastest growing stem cell account on Twitter (@StemCellMarket).
The only repeated request that I got was that we start sharing some of our direct survey results. After being asked repeatedly for this information, we’ve decided to share with you a few key insights from our recent “Survey of Stem Cell Scientists (2014).”
We are also the beginning stages of organizing our 2016 survey. Look out for that on our Shop Page soon.
Resulting from these requests, we’re going to be sharing with you:
- The Top 5 Providers of Stem Cell Products (see below)
- The 3 Most Influential Factors Impacting Researchers to Buy from You over the Competition
- The Primary Method that Stem Cell Researchers Use for Making Purchasing Decisions
Subscribe below to make sure you get all of this information.
Top 5 Providers of Stem Cell Products
In our Survey of Stem Cell Scientists (2014), we asked our participants, “Who is your preferred provider for purchasing stem cell products?”
Below is a list of the top 5 providers of stem cell products, as ranked by percentage of respondents who chose each provider.
TOP 5 PROVIDERS
1st) Thermo Fisher Scientific (Including Life Technologies brand)
2nd) STEMCELL Technologies
3rd) BD Biosciences
4th) Sigma-Aldrich (Now merged with Merck KGaA)
Congrats to those of you making the Top 5 Preferred Providers list!
Remember to check back soon to learn the three most influential factors that cause stem cell researchers to buy from you, over the competition.
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant has been featured on news outlets including the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Becton Dickinson, and Thermo Fisher Scientific, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.